Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT India 2025

Hybrid approach to Complex PCI

Presenter: Sandeep Parekh

July 26, 2025

Presentation TCT India 2025

Hybrid PCI-Less Metal More Medicine

Presenter: Sanjeev Gera

July 26, 2025

Presentation JIM 2018

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Presenter: Luca Testa

February 22, 2018

Presentation JIM 2018

“Cre8TM EVO: Establishing a new DES benchmark for diabetic patients”

Presenter: Gennaro Sardella

February 22, 2018

Presentation EuroPCR 2017

BIO-RESORT Silent Diabetes

Presenter: Clemens von Birgelen

May 19, 2017

Presentation JIM 2017

Dedicated Designed DES+ for Diabetic Patients

Presenter: Dinesh Shah

February 10, 2017

Presentation

PCI in Patients With Insulin-Treated andNon-Insulin-Treated Diabetes Mellitus

Presenter: Sripal Bangalore

April 22, 2016

Presentation

Impact of Diabetes on Outcomes After PCI With DES in Relation to CAD Complexity

Presenter: KC. Koskinas

February 02, 2016

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

Presentation

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Presenter: Mohamed Abdel-Wahab

July 23, 2015

Presentation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Presenter: K.K.W. Olesen

November 13, 2014

Presentation

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Presenter: Laurent Feldman

October 06, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation

Impact of Coronary Lesion Complexity on DES Outcomes in Patients with and Without Diabetes

Presenter: E. Kedhi

March 12, 2014

Presentation TCTAP 2013

ESSENCE-DIABETES II Trial

Presenter: Gyung-Min Park

April 25, 2013

Presentation

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Presenter: S. Deftereos

April 17, 2013

Presentation TCT 2013

Clinical Outcome of Diabetic and Non-Diabetic Patients Treated With Second-Generation Zotarolimus-Eluting and Everolimus-Eluting DES

Presenter: Kenneth Tandjung, Hanim Sen, Mounir Basalus, K Gert van Houwelingen, Marije L?wik, Martin Stoel, Frits de Man, J. Hans Louwerenburg, Gerard Linssen, Mark Nienhuis, Rogier Nijhuis, Job van der Palen, Clemens von Birgelen

January 31, 2013

Presentation

Cost-Effectiveness of PCI with DES vs. CABG for Patients with Diabetes and Multivessel CAD

Presenter: E. A. Magnuson

January 07, 2013

Presentation TCT 2012

Introducing Disruptive DES Technology into BARI 2D: Lessons Learned, Insights Gained

Presenter: Frederick Feit

October 26, 2012

Advertisement

Hybrid approach to Complex PCI

Hybrid PCI-Less Metal More Medicine

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

“Cre8TM EVO: Establishing a new DES benchmark for diabetic patients”

BIO-RESORT Silent Diabetes

Dedicated Designed DES+ for Diabetic Patients

PCI in Patients With Insulin-Treated andNon-Insulin-Treated Diabetes Mellitus

Impact of Diabetes on Outcomes After PCI With DES in Relation to CAD Complexity

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

EES vs CABG for Patients With Diabetes and Multivessel Disease

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Impact of Coronary Lesion Complexity on DES Outcomes in Patients with and Without Diabetes

ESSENCE-DIABETES II Trial

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Clinical Outcome of Diabetic and Non-Diabetic Patients Treated With Second-Generation Zotarolimus-Eluting and Everolimus-Eluting DES

Cost-Effectiveness of PCI with DES vs. CABG for Patients with Diabetes and Multivessel CAD

Introducing Disruptive DES Technology into BARI 2D: Lessons Learned, Insights Gained

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content